Drugmakers face market turmoil following FDA shakeup and Trump health overhaul
The pharma and biotech sector has been under pressure since Donald Trump returned to the White House earlier this year.
Fierce Pharma19h
Judge levies $1.64B penalty on Johnson & Johnson in HIV drug marketing case
Nearly a year after a jury decided that Johnson & Johnson should be fined just over $150 million in a lawsuit alleging that ...
Reflections On Biotech In 2025: The Spotlight On Tangible Outcomes
Even still, the pharma deals announced out of the event brought a clear message for the biotech industry. Technology ...
Drivers Of High Prescription Drug Costs And What Healthcare Leaders Can Do
With growing bipartisan support, there’s an opportunity to tackle these issues head-on, and leaders in the healthcare space ...
STAT20h
Pharmalittle: We’re reading about fallout over ousted FDA official, a Colorado pharma setback, and more
The ouster of Peter Marks, the FDA official who oversaw vaccines, gene therapies, and the blood supply, has alarmed biopharma ...
Flawed medical studies can end up in doctors’ advice. We developed a tool to stop it
Evidence suggests scientific misconduct – from fabricated or manipulated data to methodological errors and ethical concerns – ...
STAT20h
Emotional whiplash for PTC Therapeutics
Pluvicto, Novartis’ blockbuster radiopharmaceutical for prostate cancer, has been greenlighted by the FDA for use earlier in ...
Biotech Investors Rush for the Exits After FDA Official Resigns
Biotech investors are reeling after the sudden departure of Peter Marks, a pivotal figure in the U.S. Food and Drug ...